Home Privacy Archive Realtime Report

Stock Trading History of Lancaster James C Jr

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lancaster James C Jr since year 2005. The trader's CIK number is 1396927. At the time of this reporting, Lancaster James C Jr is the VP of Commercial Operations of Orexigen Therapeutics, Inc. (stock ticker symbol OREX).

Stock purchases, sales, and option exercises reported by *Lancaster James C Jr* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-12-26	OREX	Orexigen Therapeutics, Inc.	Sale	3,000	15.02	45,072
2007-12-26	OREX	Orexigen Therapeutics, Inc.	Option Exercise	3,000	2.00	6,000
2007-11-26	OREX	Orexigen Therapeutics, Inc.	Sale	3,000	14.41	43,241
2007-11-26	OREX	Orexigen Therapeutics, Inc.	Option Exercise	3,000	2.00	6,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lancaster James C Jr (VP of Commercial Operations of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.